Vanguard Group Inc Acumen Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,665,058 shares of ABOS stock, worth $3.56 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,665,058
Previous 1,839,552
9.49%
Holding current value
$3.56 Million
Previous $7.06 Million
4.53%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ABOS
# of Institutions
84Shares Held
26.8MCall Options Held
319KPut Options Held
86.3K-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$7.31 Million4.42% of portfolio
-
Franklin Resources Inc San Mateo, CA3.4MShares$7.27 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.63MShares$5.63 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$4.92 Million0.24% of portfolio
-
Laurion Capital Management LP New York, NY1.9MShares$4.06 Million0.07% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $86.7M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...